IDefine and UT Southwestern Announce Research Collaboration to Advance Gene Therapy for Rare Disease Kleefstra Syndrome

Summary

IDefine and UT Southwestern announced a research collaboration to advance gene therapy for Kleefstra Syndrome, with Dr. Steven Gray leading efforts to develop a potential therapy targeting EHMT1 gene replacement in patients with the rare neurodevelopmental disorder.